Autori: Remor Eduardo
| Naslov | Rationale for individualizing haemophilia care (Review) |
| Autori | Sorensen Benny Auerswald Guenter Benson Gary Elezovic Ivo V Felder Markus Lambert Thierry Morfini Massimo Remor Eduardo Salaj Peter Santagostino Elena Salek Silva Z Ljung Rolf |
| Info | BLOOD COAGULATION & FIBRINOLYSIS, (2015), vol. 26 br. 8, str. 849-857 |
| Projekat | Novo Nordisk Health Care AG; Sharon Eastwood of PAREXEL |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Beyond patient benefit: clinical development in hemophilia (Review) |
| Autori | Auerswald Guenter Zupancic-Salek Silva Benson Gary Elezovic Ivo V Lambert Thierry Morfini Massimo Pasi John Remor Eduardo Santagostino Elena Salaj Peter Ljung Rolf |
| Info | HEMATOLOGY, (2012), vol. 17 br. 1, str. 1-8 |
| Projekat | Novo Nordisk Region Europe A/S |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice (Review) |
| Autori | Benson Gary Auerswald Guenter Elezovic Ivo V Lambert Thierry Ljung Rolf Morfini Massimo Remor Eduardo Zupancic-Salek Silva |
| Info | EUROPEAN JOURNAL OF HAEMATOLOGY, (2012), vol. 88 br. 5, str. 371-379 |
| Projekat | Bayer; Baxter; Novo Nordisk; Octapharma; CSL Behring; Pfizer; Novo Nordisk Region Europe A/S |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | The need for speed in the management of haemophilia patients with inhibitors (Article) |
| Autori | Salek Silva Z Benson Gary Elezovic Ivo V Krenn V Ljung RCR Morfini Massimo Remor Eduardo Santagostino Elena Sorensen Benny |
| Info | HAEMOPHILIA, (2011), vol. 17 br. 1, str. 95-102 |
| Projekat | Novo Nordisk Region Europe A/S ; Novo Nordisk ; Bayer ; Baxter ; CSL Behring ; Wyeth ; Biovitrum |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
